menu
    • menu

    Company profile for NovaBay Pharmaceuticals

    NEW Drugs in Dev: 8
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market. We are currently focused primarily on commercializing prescription Avenova® for managing hygiene of the eyelids and lashes in the United States. Avenova is the only eye care product formulated with a proprietary, stable and pure form of hypochlorous acid. By replicating the antimicrobial chemicals used by white blood cel...
    NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market. We are currently focused primarily on commercializing prescription Avenova® for managing hygiene of the eyelids and lashes in the United States. Avenova is the only eye care product formulated with a proprietary, stable and pure form of hypochlorous acid. By replicating the antimicrobial chemicals used by white blood cells to fight infection, Avenova has proven in laboratory testing to have broad antimicrobial properties. Avenova removes debris from the skin on eyelids and lashes without burning or stinging.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NovaBay PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2000 Powell Street, Suite 1150 Emeryville, CA 94608
    Telephone
    Telephone
    (510) 899-8800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://novabay.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novabay
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/NovaBayPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novabay Pharma Restores NYSE American Listing Compliance
    Novabay Pharma Restores NYSE American Listing Compliance

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169876/0/en/NovaBay-Pharmaceuticals-Inc-Regains-Compliance-with-NYSE-American-Continued-Listing-Standards.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    NovaBay Pharma Reminds of Special Dividend & 2025 Annual Meeting
    NovaBay Pharma Reminds of Special Dividend & 2025 Annual Meeting

    18 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/18/3152838/0/en/NovaBay-Pharmaceuticals-Issues-a-Reminder-of-Important-Information-Regarding-the-Pending-Special-Dividend-and-Upcoming-2025-Annual-Meeting.html

    GLOBENEWSWIRE
    18 Sep 2025
    Share Share
    Novabay Pharmaceuticals Declares $0.80/Share Cash Dividend
    Novabay Pharmaceuticals Declares $0.80/Share Cash Dividend

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139613/0/en/NovaBay-Pharmaceuticals-Announces-One-Time-Special-Cash-Dividend-of-0-80-Per-Share.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    NovaBay Pharma Signs $6M Securities Agreement with David E. Lazar
    NovaBay Pharma Signs $6M Securities Agreement with David E. Lazar

    19 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/19/3136064/0/en/NovaBay-Pharmaceuticals-Enters-Into-6-Million-Securities-Purchase-Agreement-with-Investor-David-E-Lazar.html

    GLOBENEWSWIRE
    19 Aug 2025
    Share Share
    NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
    NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

    07 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250307578217/en

    BUSINESSWIRE
    07 Mar 2025
    Share Share
    NovaBay Sells Eyecare Unit & Adjourns Stockholder Meeting
    NovaBay Sells Eyecare Unit & Adjourns Stockholder Meeting

    23 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250123539123/en

    BUSINESSWIRE
    23 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search